🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great to have the exceptional Tor Biering-Sørensen, MD, MSc, MPH, PhD visiting us at Yale Cardiology as our visiting professor. We CarDS Lab had fun learning about his journey (those who made it back from #ACC25). Looking forward to his grand rounds @ 5p ET - live on youtube.com/@yalecardiology

Rationale and Design of NUDGE-CKD: A Nationwide Randomized Factorial Trial of Electronic Nudges for Increasing Guideline-Directed Medical Therapy in Chronic Kidney Disease From Tor Biering-Sørensen, MD, MSc, MPH, PhD and team: sciencedirect.com/science/articl…

Great comment from Cardiology Today on our recent study just out in JACC Journals jacc.org/doi/abs/10.101… CTCPR Trials & CIRL Tor Biering-Sørensen, MD, MSc, MPH, PhD

“Given our results, it would be important to assess the effect of the RSV vaccines on cardiorespiratory hospitalization endpoints,” Mats C. Højbjerg Lassen, MD of CTCPR Trials & CIRL told Healio #cardiotwitter #ACC25 healio.com/news/cardiolog…

I also see this as a great example of what a figure can look like as a JACC brief report. 🇩🇰 Kudos to the authors and our in-house illustrators. Mats C. Højbjerg Lassen, MD Tor Biering-Sørensen, MD, MSc, MPH, PhD JACC Journals

Our recent paper highlighted in JACC Journals

In Denmark, CVD affects 11% of the population—but with universal healthcare, registry-based research, and bold public health moves, outcomes are improving. Equity is the next frontier. ❤️ Anne Marie Reimer Jensen Caroline Espersen Tor Biering-Sørensen, MD, MSc, MPH, PhD ahajournals.org/doi/full/10.11…

Risk assessment through HFA/IC-OS stratification tool in breast cancer patients undergoing #HER2-inhibitors: the way for optimizing resource use without compromising cardiovascular safety? jacc.org/doi/10.1016/j.… #JACCCardioOnc #CardioOnc #BCsm #LVEF

Outstanding sci. statement from Sadiya Khan Don Lloyd-Jones et al on primary prev of HF. #PREVENTHF now enrolling, studying ASi+SGLT2i in >11k at risk participants, highlighting a new era for HF PREVENTION! clinicaltrials.gov/study/NCT06677… Muthu Vaduganathan scottdavidsolomon Maja Cikes Tor Biering-Sørensen, MD, MSc, MPH, PhD

CV hosp rates among older adults in the US compared to Denmark 🇩🇰 🇺🇸 excited to have contributed to this collaborative work with Rishi Wadhera, MD MPP Tor Biering-Sørensen, MD, MSc, MPH, PhD Muthu Vaduganathan led by Frederikke Berg

📽️ Tor Biering-Sørensen presented the analysis of the primary and secondary endpoint results of the DECODE-CKD at #ACC25. -> medicaldigest.org/scientific-con… Tor Biering-Sørensen, MD, MSc, MPH, PhD CTCPR Trials & CIRL ACC Media Center American College of Cardiology #CardioTwitter

🤩Simultaneous publication for NUDGE CKD trial in Circulation #ERA25

Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in CKD #ERA25 Evaluating if a single electronic letter can increase GDMT use in patients with CKD. sciencedirect.com/science/articl…

#NUDGECKD in Circulation #ERA25 by Kristoffer Grundtvig Skaarup & Tor Biering-Sørensen, MD, MSc, MPH, PhD Nationwide 2x2 Pragmatic Implementation Mega-Trial 👥 n=22,617 🇩🇰 adults w #CKD 🥼n=1540 General practitioners Electronic nudges did not improve uptake of #RASi or #SGLT2i versus usual care ahajournals.org/doi/10.1161/CI…

Pooled analysis of obesity and kidney outcomes from 4 HFpEF RCTs now in JACC Journals 👥 n=16,919 ⬆️ waist circumference ➡️ higher kidney risk🫘🏥 ⬆️ waist-to-height ratio ➡️ higher kidney risk 🫘🏥 But not for BMI 🤔 sciencedirect.com/science/articl… Muthu Vaduganathan Tor Biering-Sørensen, MD, MSc, MPH, PhD

HFimpEF is on the rise, but recovery isn’t the end of the story. Our latest review dives into what we know (and don’t) about its prognosis, treatment, and outcomes jacc.org/doi/full/10.10…

📢 Research shows: Vaginal estradiol use not linked to increased risk of recurrent venous thromboembolism (VTE) in women with prior VTE. ⚖️ Nationwide nested case-control study (n=44,024) 📉 HR for current use: 0.75, p = 0.07 🔗 doi.org/10.1111/ejh.14…

CTCPR Trials & CIRL strongly represented at the annual Danish Cardiovascular Academy summer meeting: Flemming Javier Olsen on progeria and Julie Borchsenius on psoriasis!

Tor Biering-Sørensen, MD, MSc, MPH, PhD CTCPR Trials & CIRL JAMA Brilliant design Tor Biering-Sørensen, MD, MSc, MPH, PhD. Another example of CTCPR Trials & CIRL leading rapid cycle randomized clinical trials at scale. Niklas Dyrby Johansen

The very first paper from DANFLU-2 - the largest individually randomized influenza vaccine RCT ever conducted – is officially out in JAMA: An RCT embedded into the recruitment phase testing the impact of recruitment letter design and color scheme. ja.ma/3Gfixqa